Gilteritinib-induced severe immune-related enteritis: a possible case report

Pan Luo1,2, Huiying Qiu3, Yushan Yang1,4

  • 1Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.

Anti-Cancer Drugs
|May 4, 2023
PubMed
Summary

This case report details a severe immune-related enteritis possibly caused by gilteritinib in a patient with FLT3-mutated acute myeloid leukemia. Early detection of this adverse drug reaction is crucial for patient management.